Insider Selling: UnitedHealth Group Inc (NYSE:UNH) Director Sells 10,000 Shares of Stock

UnitedHealth Group Inc (NYSE:UNH) Director Michele J. Hooper sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total transaction of $2,377,600.00. Following the sale, the director now owns 37,284 shares in the company, valued at $8,864,643.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of UnitedHealth Group Inc (NYSE:UNH) traded up $4.50 on Friday, hitting $220.96. 6,208,110 shares of the stock were exchanged, compared to its average volume of 4,150,000. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58. The stock has a market capitalization of $214,130.00, a price-to-earnings ratio of 20.63, a PEG ratio of 1.29 and a beta of 0.70. UnitedHealth Group Inc has a twelve month low of $156.49 and a twelve month high of $250.79.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period last year, the firm posted $2.11 earnings per share. analysts expect that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Alexandria Capital LLC lifted its holdings in shares of UnitedHealth Group by 5,310.4% during the fourth quarter. Alexandria Capital LLC now owns 12,498 shares of the healthcare conglomerate’s stock worth $2,755,000 after purchasing an additional 12,267 shares during the period. Sequoia Wealth Management LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $222,000. Timber Hill LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $2,325,000. GM Advisory Group Inc. lifted its holdings in shares of UnitedHealth Group by 80.5% during the fourth quarter. GM Advisory Group Inc. now owns 3,451 shares of the healthcare conglomerate’s stock worth $761,000 after purchasing an additional 1,539 shares during the period. Finally, Baird Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Baird Financial Group Inc. now owns 227,200 shares of the healthcare conglomerate’s stock worth $50,089,000 after purchasing an additional 970 shares during the period. 86.24% of the stock is owned by hedge funds and other institutional investors.

Several brokerages have commented on UNH. Deutsche Bank increased their price target on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. Wells Fargo & Co reiterated an “outperform” rating and issued a $245.00 price target (up from $230.00) on shares of UnitedHealth Group in a research note on Wednesday, November 29th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research note on Friday, December 1st. Citigroup increased their price target on shares of UnitedHealth Group from $213.00 to $235.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Finally, BMO Capital Markets began coverage on shares of UnitedHealth Group in a research note on Monday, October 16th. They issued an “outperform” rating and a $250.00 price target on the stock. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $243.22.

ILLEGAL ACTIVITY WARNING: “Insider Selling: UnitedHealth Group Inc (NYSE:UNH) Director Sells 10,000 Shares of Stock” was first published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://ledgergazette.com/2018/02/11/unitedhealth-group-inc-unh-director-sells-2377600-00-in-stock.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply